End pharma influence on CME, says AMA journalBMJ 2006; 332 doi: http://dx.doi.org/10.1136/bmj.332.7555.1410 (Published 15 June 2006) Cite this as: BMJ 2006;332:1410
- Janice Tanne
- New York
The American Medical Association's ethics journal has suggested reducing drug companies' influence on doctors' prescribing habits by stopping the companies paying for continuing medical education (CME; American Medical Association Journal of Ethics 2006;46:357-436).
Such education is required in most US states and by many medical societies. The journal devoted its entire June issue to ways to reduce or manage drug company influence on doctors.
In 2004, more than $2bn (£1.1bn; €1.6bn) was spent on continuing medical education. Medical communications companies and medical schools depend heavily on drug companies to develop educational programmes, say the authors, Dr Adriane Fugh-Berman, an adjunct associate professor and specialist in complementary and alternative medicine at Georgetown …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial